CELL SEARCH SYSTEM -CELL BANK- (RIKEN BRC) [RCB2292 : ACC-MESO-1]

16027 Matsushita A, Sato T, Mukai S, Fujishita T, Mishiro-Sato E, Okuda M, Aoki M, Hasegawa Y, Sekido Y. TAZ activation by Hippo pathway dysregulation induces cytokine gene expression and promotes mesothelial cell transformation Oncogene 2018 38(11):1966-1978 PubMed ID: 30401981 DOI: 10.1038/s41388-018-0417-7

16469 Tanaka I, Osada H, Fujii M, Fukatsu A, Hida T, Horio Y, Kondo Y, Sato A, Hasegawa Y, Tsujimura T, Sekido Y. LIM-domain protein AJUBA suppresses malignant mesothelioma cell proliferation via Hippo signaling cascade Oncogene 2015 34(1):73-83 PubMed ID: 24336325 DOI: 10.1038/onc.2013.528

16471 Mizuno T, Murakami H, Fujii M, Ishiguro F, Tanaka I, Kondo Y, Akatsuka S, Toyokuni S, Yokoi K, Osada H, Sekido Y. YAP induces malignant mesothelioma cell proliferation by upregulating transcription of cell cycle-promoting genes Oncogene 2012 31(49):5117-22 PubMed ID: 22286761 DOI: 10.1038/onc.2012.5

3337 Usami, Noriyasu, Fukui, Takayuki, Kondo, Masashi, Taniguchi, Tetsuo, Yokoyama, Toshihiko, Mori, Shoichi, Yokoi, Kohei, Horio, Yoshitsugu, Shimokata, Kaoru, Sekido, Yoshitaka, Hida, Toyoaki Establishment and characterization of four malignant pleural mesothelioma cell lines from Japanese patients. Cancer Sci 2006 97:387-94 PubMed ID: 16630136 DOI: 10.1111/j.1349-7006.2006.00184.x

Top

User's Publication

22728 Kirimura S, Kurata M, Ishibashi H, Taniguchi Y, Kinowaki Y, Sugita K, Okubo K. Cytoplasmic HuR Expression Enhances Chemoresistance in Pleural Mesothelioma Through Increased Expression of CALB2, Promotion of the E2F Pathway, and Suppression of the p53 Pathway. Thorac Cancer 2025 16(7):e70062 PubMed ID: 40200787 DOI: 10.1111/1759-7714.70062

21908 Ito M, Koido S, Iwamoto T, Morimoto S, Fujiki F, Sugiyama H, Matsumoto S, Effenberger C, Kiyotani K, Shiba K. Enhancing the immunogenicity of Wilms tumor 1 epitope in mesothelioma cells with immunoproteasome inhibitors. PLoS One 2024 19(8):e0308330 PubMed ID: 39116074 DOI: 10.1371/journal.pone.0308330

22533 Staining, magnification, and algorithmic conditions for highly accurate cell detection and cell classification by deep learning Staining, magnification, and algorithmic conditions for highly accurate cell detection and cell classification by deep learning Am J Clin Pathol 2024 161(4):399-410 PubMed ID: 38134350 DOI: 10.1093/ajcp/aqad162

19593 Kreienbühl J, Changkhong S, Orlowski V, Kirschner MB, Opitz I, Meerang M. Cullin 4B Ubiquitin Ligase Is Important for Cell Survival and Regulates TGF-β1 Expression in Pleural Mesothelioma Int J Mol Sci 2023 24(17):13410 PubMed ID: 37686215 DOI: 10.3390/ijms241713410

19685 Sakabe N, Maruyama S, Ito C, Shimoyama Y, Komene T, Oboshi W, Sato S, Sudo K, Ikeda K. Immunocytochemical Reactivity Comparison between Formalin-Fixed and Liquid-Based Cytology-Fixed Specimens Acta Cytol 2023 67(1):38-45 PubMed ID: 36228592 DOI: 10.1159/000526131

19753 Endo I, Amatya VJ, Kushitani K, Nakagiri T, Aoe K, Takeshima Y. Long Non-coding RNA LINC00152 Requires EZH2 to Promote Mesothelioma Cell Proliferation, Migration, and Invasion Anticancer Res 2023 43(12):5367-5376 PubMed ID: 38030172 DOI: 10.21873/anticanres.16740

19758 Endo I, Amatya VJ, Kushitani K, Nakagiri T, Aoe K, Takeshima Y. miR-142-3p Suppresses Invasion and Adhesion of Mesothelioma Cells by Downregulating ITGAV Pathobiology 2023 90(4):270-280 PubMed ID: 36724751 DOI: 10.1159/000528670

19954 Okamura K, Inoue H, Tanaka K, Ikematsu Y, Furukawa R, Ota K, Yoneshima Y, Iwama E, Okamoto I. Immunostimulatory oncolytic activity of coxsackievirus A11 in human malignant pleural mesothelioma Cancer Sci 2023 114(3):1095-1107 PubMed ID: 36369966 DOI: 10.1111/cas.15645

21058 Yang H, Gao Y, Xu D, Xu K, Liang SQ, Yang Z, Scherz A, Hall SRR, Forster S, Berezowska S, Yao F, Ochsenbein AF, Marti TM, Kocher GJ, Schmid RA, Dorn P, Peng RW. MEK1 drives oncogenic signaling and interacts with PARP1 for genomic and metabolic homeostasis in malignant pleural mesothelioma. Cell Death Discov 2023 9(1):55 PubMed ID: 36765038 DOI: 10.1038/s41420-023-01307-2

21089 Sakura K, Sasai M, Funaki S, Shintani Y, Okumura M, Kaneda Y. Add-On Effect of Hemagglutinating Virus of Japan Envelope Combined with Chemotherapy or Immune Checkpoint Inhibitor against Malignant Pleural Mesothelioma: An In Vivo Study. Cancers (Basel) 2023 15(3) PubMed ID: 36765886 DOI: 10.3390/cancers15030929

21383 Endo I, Amatya VJ, Kushitani K, Kambara T, Nakagiri T, Aoe K, Takeshima Y. FOXM1 Promotes Mesothelioma Cell Migration and Invasion via Activation of SMAD Signaling. Anticancer Res 2023 43(9):3961-3968 PubMed ID: 37648326 DOI: 10.21873/anticanres.16583

21461 Nakagiri T, Amatya VJ, Kushitani K, Kambara T, Aoe K, Endo I, Miyata Y, Okada M, Takeshima Y. SPARC Is a Novel Positive Immunohistochemical Marker of Epithelioid Mesothelioma to Differentiate It From Lung Adenocarcinoma and/or Squamous Cell Carcinoma. Am J Surg Pathol 2023 PubMed ID: 37899530 DOI: 10.1097/PAS.0000000000002147

17557 Tomita R, Nishijo N, Hayama T, Fujioka T. Discrimination of Malignant Pleural Mesothelioma Cell Lines Using Amino Acid Metabolomics with HPLC Biol Pharm Bull 2022 45(6):724-729. PubMed ID: 35650101 DOI: 10.1248/bpb.b21-00972

17590 Hagiyama M, Mimae T, Wada A, Takeuchi F, Yoneshige A, Inoue T, Kotoku N, Hamada H, Sekido Y, Okada M, Ito A. Possible Therapeutic Utility of anti-Cell Adhesion Molecule 1 Antibodies for Malignant Pleural Mesothelioma Front Cell Dev Biol 2022 10:945007 PubMed ID: 35903548 DOI: 10.3389/fcell.2022.945007

17671 Endo I, Amatya VJ, Kushitani K, Kambara T, Nakagiri T, Fujii Y, Takeshima Y. Insulin-Like Growth Factor 2 mRNA Binding Protein 3 Promotes Cell Proliferation of Malignant Mesothelioma Cells by Downregulating p27Kip1 Front Oncol 2022 11:795467 PubMed ID: 35127504 DOI: 10.3389/fonc.2021.795467

20462 Fujii Y, Amatya VJ, Kushitani K, Suzuki R, Kai Y, Kambara T, Takeshima Y. Downregulation of lncRNA PVT1 inhibits proliferation and migration of mesothelioma cells by targeting FOXM1. Oncol Rep 2022 47(2) PubMed ID: 34859258 DOI: 10.3892/or.2021.8238

20801 Hasegawa M, Hanamatsu Y, Saigo C, Kito Y, Takeuchi T. Tumor suppressor effect of an antibody on xenotransplanted sarcomatoid mesothelioma cells. Thorac Cancer 2022 PubMed ID: 35916358 DOI: 10.1111/1759-7714.14591

20093 Yang H, Hall SRR, Sun B, Zhao L, Gao Y, Schmid RA, Tan ST, Peng RW, Yao F. NF2 and Canonical Hippo-YAP Pathway Define Distinct Tumor Subsets Characterized by Different Immune Deficiency and Treatment Implications in Human Pleural Mesothelioma. Cancers (Basel) 2021 13(7) PubMed ID: 33805359 DOI: 10.3390/cancers13071561

20510 Takasaka M, Kobayashi S, Usui Y, Haniu H, Tsuruoka S, Aoki K, Saito N. Biokinetic Evaluation of Contrast Media Loaded Carbon Nanotubes Using a Radiographic Device. Toxics 2021 9(12) PubMed ID: 34941765 DOI: 10.3390/toxics9120331

20560 Abukar A, Wipplinger M, Hariharan A, Sun S, Ronner M, Sculco M, Okonska A, Kresoja-Rakic J, Rehrauer H, Qi W, Beusechem VWV, Felley-Bosco E. Double-Stranded RNA Structural Elements Holding the Key to Translational Regulation in Cancer: The Case of Editing in RNA-Binding Motif Protein 8A. Cells 2021 10(12) PubMed ID: 34944051 DOI: 10.3390/cells10123543

16120 Kanayama M, Oyama R, Mori M, Taira A, Shinohara S, Kuwata T, Takenaka M, Yoneda K, Kuroda K, Ohnaga T, Kato Y, Tanaka F. Novel circulating tumor cell-detection chip combining conventional podoplanin and EGFR antibodies for all histological malignant pleural mesothelioma Oncol Lett 2021 22(1):522 PubMed ID: 34025789 DOI: 10.3892/ol.2021.12783

6938 Okonska A, Bühler S, Rao V, Ronner M, Blijlevens M, van der Meulen-Muileman IH, de Menezes RX, Wipplinger M, Oehl K, Smit EF, Weder W, Stahel RA, Penengo L, van Beusechem VW, Felley-Bosco E. Functional genomic screen in mesothelioma reveals that loss of function of BRCA1-associated-protein-1 induces chemoresistance to ribonucleotide reductase inhibition. Mol Cancer Ther 2020 19(2):552-563 PubMed ID: 31619462 DOI: 10.1158/1535-7163.MCT-19-0356

12125 Fujii T, Itami H, Uchiyama T, Morita K, Nakai T, Hatakeyama K, Sugimoto A, Shimada K, Tsuji S, Ohbayashi C. HEG1-responsive microRNA-23b regulates cell proliferation in malignant mesothelioma cells. Biochem. Biophys. Res. Commun. 2020 PubMed ID: 32284171 DOI: 10.1016/j.bbrc.2020.03.172

13171 Yang H, Xu D, Yang Z, Yao F, Zhao H, Schmid RA, Peng RW. Systematic Analysis of Aberrant Biochemical Networks and Potential Drug Vulnerabilities Induced by Tumor Suppressor Loss in Malignant Pleural Mesothelioma. Cancers (Basel) 2020 PubMed ID: 32824422 DOI: 10.3390/cancers12082310

13236 Jotatsu T, Izumi H, Morimoto Y, Yatera K. Selection of microRNAs in extracellular vesicles for diagnosis of malignant pleural mesothelioma by in vitro analysis. Oncol Rep 2020 PubMed ID: 33000251 DOI: 10.3892/or.2020.7778

13275 Sakai K, Nishiuchi T, Tange S, Suzuki Y, Yano S, Terashima M, Suzuki T, Matsumoto K. Proteasomal degradation of polycomb-group protein CBX6 confers MMP-2 expression essential for mesothelioma invasion. Sci Rep 2020 PubMed ID: 33028834 DOI: 10.1038/s41598-020-72448-y

13551 Han B, Lee-Okada HC, Ishimine M, Orita H, Nishikawa K, Takagaki T, Kajino K, Yokomizo T, Hino O, Kobayashi T. Combined use of irinotecan and p53 activator enhances growth inhibition of mesothelioma cells FEBS Open Bio 2020 10(11):2375-2387 PubMed ID: 32961616 DOI: 10.1002/2211-5463.12985

13608 Kuwata T, Yoneda K, Mori M, Kanayama M, Kuroda K, Kaneko MK, Kato Y, Tanaka F. Detection of Circulating Tumor Cells (CTCs) in Malignant Pleural Mesothelioma (MPM) with the "Universal" CTC-Chip and An Anti-Podoplanin Antibody NZ-1.2 Cells 2020 9(4):888 PubMed ID: 32260559 DOI: 10.3390/cells9040888

14504 Suzuki R, Amatya VJ, Kushitani K, Kai Y, Kambara T, Fujii Y, Takeshima Y. Inhibition of miR-18a-3p reduces proliferation of mesothelioma cells and sensitizes them to cisplatin Oncol Lett 2020 19(6):4161-4168 PubMed ID: 32382354 DOI: 10.3892/ol.2020.11504

10679 Yoneda K, Chikaishi Y, Kuwata T, Ohnaga T, Tanaka F. Capture of mesothelioma cells with 'universal' CTC-chip. Oncol Lett 2018 15:2635-2640 PubMed ID: 29434985 DOI: 10.3892/ol.2017.7619

11150 Ohno Y, Shingyoku S, Miyake S, Tanaka A, Fudesaka S, Shimizu Y, Yoshifuji A, Yamawaki Y, Yoshida S, Tanaka S, Sakura K, Tanaka T. Differential regulation of the sphere formation and maintenance of cancer-initiating cells of malignant mesothelioma via CD44 and ALK4 signaling pathways. Oncogene 2018 37(49):6357-6367 PubMed ID: 30061637 DOI: 10.1038/s41388-018-0405-y

11207 Okamoto T, Yamazaki H, Hatano R, Yamada T, Kaneko Y, Xu CW, Dang NH, Ohnuma K, Morimoto C. Targeting CD26 suppresses proliferation of malignant mesothelioma cell via downmodulation of ubiquitin-specific protease 22. Biochem. Biophys. Res. Commun. 2018 PubMed ID: 30197002 DOI: 10.1016/j.bbrc.2018.08.193

11107 Xu D, Liang SQ, Yang H, Luthi U, Riether C, Berezowska S, Marti TM, Hall SRR, Bruggmann R, Kocher GJ, Schmid RA, Peng RW. Increased sensitivity to apoptosis upon endoplasmic reticulum stress-induced activation of the unfolded protein response in chemotherapy-resistant malignant pleural mesothelioma. Br. J. Cancer 2018 119(1):65-75 PubMed ID: 29921948 DOI: 10.1038/s41416-018-0145-3

11217 Matsuura R, Kaji H, Tomioka A, Sato T, Narimatsu H, Moriwaki Y, Misawa H, Imai K, Tsuji S. Identification of mesothelioma-specific sialylated epitope recognized with monoclonal antibody SKM9-2 in a mucin-like membrane protein HEG1. Sci Rep 2018 PubMed ID: 30250045 DOI: 10.1038/s41598-018-32534-8

4469 Suzuki R, Amatya VJ, Kushitani K, Kai Y, Kambara T, Takeshima Y. miR-182 and miR-183 Promote Cell Proliferation and Invasion by Targeting FOXO1 in Mesothelioma. Front Oncol 2018 8:446 PubMed ID: 30406026 DOI: 10.3389/fonc.2018.00446

7034 Tsuji S, Washimi K, Kageyama T, Yamashita M, Yoshihara M, Matsuura R, Yokose T, Kameda Y, Hayashi H, Morohoshi T, Tsuura Y, Yusa T, Sato T, Togayachi A, Narimatsu H, Nagasaki T, Nakamoto K, Moriwaki Y, Misawa H, Hiroshima K, Miyagi Y, Imai K. HEG1 is a novel mucin-like membrane protein that serves as a diagnostic and therapeutic target for malignant mesothelioma. Sci Rep 2017 7:45768 PubMed ID: 28361969 DOI: 10.1038/srep45768

14252 Maki T, Ikeda H, Kuroda A, Kyogoku N, Yamamura Y, Tabata Y, Abiko T, Tsuchikawa T, Hida Y, Shichinohe T, Tanaka E, Kaga K, Hatanaka K, Matsuno Y, Imai N, Hirano S. Differential detection of cytoplasmic Wilms tumor 1 expression by immunohistochemistry, western blotting and mRNA quantification Int J Oncol 2017 50(1):129-140. PubMed ID: 27922671 DOI: 10.3892/ijo.2016.3786

14253 Satoh T, Tatsuta T, Sugawara S, Hara A, Hosono M. Synergistic anti-tumor effect of bullfrog sialic acid-binding lectin and pemetrexed in malignant mesothelioma Oncotarget 2017 8(26):42466-42477 PubMed ID: 28476017 DOI: 10.18632/oncotarget.17198

14487 Mawas AS, Amatya VJ, Suzuki R, Kushitani K, Mohi El-Din MM, Takeshima Y. PIM1 knockdown inhibits cell proliferation and invasion of mesothelioma cells Int J Oncol 2017 50(3):1029-1034 PubMed ID: 28197633 DOI: 10.3892/ijo.2017.3863

9731 Mizutani N, Abe M, Matsuoka S, Kajino K, Wakiya M, Ohtsuji N, Hatano R, Morimoto C, Hino O. Establishment of anti-mesothelioma monoclonal antibodies. BMC Res Notes 2016 9:324 PubMed ID: 27342200 DOI: 10.1186/s13104-016-2128-x

12632 Amatya VJ, Mawas AS, Kushitani K, Mohi El-Din MM, Takeshima Y. Differential microRNA expression profiling of mesothelioma and expression analysis of miR-1 and miR-214 in mesothelioma Int J Oncol 2016 48(4):1599-607 PubMed ID: 26820394 DOI: 10.3892/ijo.2016.3358

12672 Seki Y, Fujiwara Y, Kohno T, Takai E, Sunami K, Goto Y, Horinouchi H, Kanda S, Nokihara H, Watanabe S, Ichikawa H, Yamamoto N, Kuwano K, Ohe Y. Picoliter-Droplet Digital Polymerase Chain Reaction-Based Analysis of Cell-Free Plasma DNA to Assess EGFR Mutations in Lung Adenocarcinoma That Confer Resistance to Tyrosine-Kinase Inhibitors Oncologist 2016 21(2):156-64 PubMed ID: 26768482 DOI: 10.1634/theoncologist.2015-0288

12680 Kushitani K, Amatya VJ, Mawas AS, Miyata Y, Okada M, Takeshima Y. Use of Anti-Noxa Antibody for Differential Diagnosis between Epithelioid Mesothelioma and Reactive Mesothelial Hyperplasia Pathobiology 2016 83(1):33-40 PubMed ID: 26735863 DOI: 10.1159/000442092

12937 Hida T, Hamasaki M, Matsumoto S, Sato A, Tsujimura T, Kawahara K, Iwasaki A, Okamoto T, Oda Y, Honda H, Nabeshima K. BAP1 immunohistochemistry and p16 FISH results in combination provide higher confidence in malignant pleural mesothelioma diagnosis: ROC analysis of the two tests Pathol Int 2016 66(10):563-570. PubMed ID: 27614970 DOI: 10.1111/pin.12453

5349 Maruyama K, Haniu H, Saito N, Matsuda Y, Tsukahara T, Kobayashi S, Tanaka M, Aoki K, Takanashi S, Okamoto M, Kato H. Endocytosis of Multiwalled Carbon Nanotubes in Bronchial Epithelial and Mesothelial Cells Biomed Res Int 2015 2015:793186 PubMed ID: 26090445 DOI: 10.1155/2015/793186

19326 Haniu H, Saito N, Matsuda Y, Tsukahara T, Usui Y, Maruyama K, Takanashi S, Aoki K, Kobayashi S, Nomura H, Tanaka M, Okamoto M, Kato H. Biological responses according to the shape and size of carbon nanotubes in BEAS-2B and MESO-1 cells Int J Nanomedicine 2014 9:1979-90 PubMed ID: 24790438 DOI: 10.2147/IJN.S58661

3916 Okabe S, Okamoto T, Zhao CM, Chen D, Matsui H. Acetic acid induces cell death: an in vitro study using normal rat gastric mucosal cell line and rat and human gastric cancer and mesothelioma cell lines. J Gastroenterol Hepatol 2014 29 Suppl 4:65-9 PubMed ID: 25521736 DOI: 10.1111/jgh.12775

9149 Yoshikane Yamauchi, Yotaro Izumi, Keisuke Asakura, Yuichiro Hayashi, Hiroaki Nomori Curcumin Induces Autophagy in ACC-MESO-1 Cells Phytother Res 2012 26 (12), 1779-83 PubMed ID: 22388865 DOI: 10.1002/ptr.4645

7592 Haniu H, Saito N, Matsuda Y, Kim YA, Park KC, Tsukahara T, Usui Y, Aoki K, Shimizu M, Ogihara N, Hara K, Takanashi S, Okamoto M, Ishigaki N, Nakamura K, Kato H. Effect of dispersants of multi-walled carbon nanotubes on cellular uptake and biological responses. Int J Nanomedicine 2011 6:3295-307 PubMed ID: 22228997 DOI: 10.2147/IJN.S26573

7727 Asakura K, Izumi Y, Yamamoto M, Yamauchi Y, Kawai K, Serizawa A, Mizushima T, Ohmura M, Kawamura M, Wakui M, Adachi T, Nakamura M, Suematsu M, Nomori H. The cytostatic effects of lovastatin on ACC-MESO-1 cells. J. Surg. Res. 2011 170:e197-209 PubMed ID: 21816418 DOI: 10.1016/j.jss.2011.06.037

7784 Yamauchi Y, Izumi Y, Asakura K, Fukutomi T, Serizawa A, Kawai K, Wakui M, Suematsu M, Nomori H. Lovastatin and valproic acid additively attenuate cell invasion in ACC-MESO-1 cells. Biochem. Biophys. Res. Commun. 2011 410:328-32 PubMed ID: 21672521 DOI: 10.1016/j.bbrc.2011.05.149

8088 Iwahori K, Serada S, Fujimoto M, Nomura S, Osaki T, Lee CM, Mizuguchi H, Takahashi T, Ripley B, Okumura M, Kawase I, Kishimoto T, Naka T. Overexpression of SOCS3 exhibits preclinical antitumor activity against malignant pleural mesothelioma. Int. J. Cancer 2011 129:1005-17 PubMed ID: 20949562 DOI: 10.1002/ijc.25716

8199 Hasegawa S, Koshikawa-Yano M, Saito S, Morokoshi Y, Furukawa T, Aoki I, Saga T. Molecular imaging of mesothelioma by detection of manganese-superoxide dismutase activity using manganese-enhanced magnetic resonance imaging. Int. J. Cancer 2011 128:2138-46 PubMed ID: 20617513 DOI: 10.1002/ijc.25547

19029 Kanamori-Katayama M, Kaiho A, Ishizu Y, Okamura-Oho Y, Hino O, Abe M, Kishimoto T, Sekihara H, Nakamura Y, Suzuki H, Forrest AR, Hayashizaki Y. LRRN4 and UPK3B are markers of primary mesothelial cells PLoS One 2011 6(10):e25391 PubMed ID: 21984916 DOI: 10.1371/journal.pone.0025391

5413 Haniu H, Saito N, Matsuda Y, Kim YA, Park KC, Tsukahara T, Usui Y, Aoki K, Shimizu M, Ogihara N, Hara K, Takanashi S, Okamoto M, Ishigaki N, Nakamura K, Kato H. Elucidation mechanism of different biological responses to multi-walled carbon nanotubes using four cell lines. Int J Nanomedicine 2011 6:3487-97 PubMed ID: 22267932 DOI: 10.2147/IJN.S26689

16309 Haniu H, Tsukahara T, Matsuda Y, Usui Y, Aoki K, Shimizu M, Ogihara N, Hara K, Takanashi S, Okamoto M, Ishigaki N, Nakamura K, Kato H, Saito N. DJ-1 as a potential biomarker for the development of biocompatible multiwalled carbon nanotubes Int J Nanomedicine 2011 6:2689-95 PubMed ID: 22114499 DOI: 10.2147/IJN.S25471

8186 Tsuji S, Tsuura Y, Morohoshi T, Shinohara T, Oshita F, Yamada K, Kameda Y, Ohtsu T, Nakamura Y, Miyagi Y. Secretion of intelectin-1 from malignant pleural mesothelioma into pleural effusion. Br. J. Cancer 2010 103:517-23 PubMed ID: 20628387 DOI: 10.1038/sj.bjc.6605786

8379 Suzuki Y, Sakai K, Ueki J, Xu Q, Nakamura T, Shimada H, Nakamura T, Matsumoto K. Inhibition of Met/HGF receptor and angiogenesis by NK4 leads to suppression of tumor growth and migration in malignant pleural mesothelioma. Int. J. Cancer 2010 127:1948-57 PubMed ID: 20104519 DOI: 10.1002/ijc.25197

18472 Nabeta M, Abe Y, Kagawa L, Haraguchi R, Kito K, Ueda N, Sugita A, Yokoyama M, Kusanagi Y, Ito M. Identification of anti-α-enolase autoantibody as a novel serum marker for endometriosis Proteomics Clin Appl 2009 3(10):1201-10 PubMed ID: 21136944 DOI: 10.1002/prca.200900055

19005 Hasegawa S, Koshikawa M, Takahashi I, Hachiya M, Furukawa T, Akashi M, Yoshida S, Saga T. Alterations in manganese, copper, and zinc contents, and intracellular status of the metal-containing superoxide dismutase in human mesothelioma cells J Trace Elem Med Biol 2008 22(3):248-55 PubMed ID: 18755401 DOI: 10.1016/j.jtemb.2008.05.001

13735 Ito A, Hagiyama M, Mimura T, Matsumoto M, Wakayama T, Iseki S, Yokozaki H, Okada M. Expression of cell adhesion molecule 1 in malignant pleural mesothelioma as a cause of efficient adhesion and growth on mesothelium Lab Invest 2008 88(5):504-14 PubMed ID: 18332875 DOI: 10.1038/labinvest.2008.15

16153 Ishida T, Obata Y, Ohara N, Matsushita H, Sato S, Uenaka A, Saika T, Miyamura T, Chayama K, Nakamura Y, Wada H, Yamashita T, Morishima T, Old LJ, Nakayama E. Identification of the HERV-K gag antigen in prostate cancer by SEREX using autologous patient serum and its immunogenicity Cancer Immun 2008 8:15. PubMed ID: 19006261

19343 Aung W, Hasegawa S, Furukawa T, Saga T. Potential role of ferritin heavy chain in oxidative stress and apoptosis in human mesothelial and mesothelioma cells: implications for asbestos-induced oncogenesis Carcinogenesis 2007 28(9):2047-52 PubMed ID: 17434931 DOI: 10.1093/carcin/bgm090